Inventor
SEHGAL LAKSHMAN R
US37 patents
⚠️ This page may combine multiple inventors who share the name “SEHGAL LAKSHMAN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEHGAL LAKSHMAN R
17 patentsUS8877060B2Nov 4, 2014
Methods for removing pathogens from a platelet preparation
SEHGAL LAKSHMAN R17 citations84
US8715920B2May 6, 2014
Composition for preserving platelets during photosensitization
SEHGAL LAKSHMAN R9 citations84
US8142992B2Mar 27, 2012
Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
SEHGAL LAKSHMAN R8 citations83
US8129104B2Mar 6, 2012
Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin
SEHGAL LAKSHMAN R6 citations83
US8329389B2Dec 11, 2012
Composition containing short-to-ultrashort GPIIb/IIIa and factor Xa inhibitors and platelets
SEHGAL LAKSHMAN R4 citations74
US8129103B2Mar 6, 2012
Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
SEHGAL LAKSHMAN R4 citations73
US8232044B2Jul 31, 2012
Method of extending the shelf life of platelets using a composition comprising a short-to-ultrashort antiplatelet agent and anticoagulant and an oxygen carrier
SEHGAL LAKSHMAN R2 citations63
US8236300B2Aug 7, 2012
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
SEHGAL LAKSHMAN R1 citations62
US9388427B2Jul 12, 2016
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
SEHGAL LAKSHMAN R0 citations52
US9353383B2May 31, 2016
Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
SEHGAL LAKSHMAN R0 citations52
US9095818B2Aug 4, 2015
Method of filtering platelets to remove antiplatelet and anticoagulant agents
SEHGAL LAKSHMAN R0 citations52
US8927203B2Jan 6, 2015
Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant
SEHGAL LAKSHMAN R0 citations52
US8697347B2Apr 15, 2014
Composition for preserving platelets and method of using the same
SEHGAL LAKSHMAN R0 citations52
US8470521B2Jun 25, 2013
Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration
SEHGAL LAKSHMAN R0 citations52
US8431334B2Apr 30, 2013
Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration
SEHGAL LAKSHMAN R0 citations52
US8420075B2Apr 16, 2013
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
SEHGAL LAKSHMAN R0 citations52
US8242095B2Aug 14, 2012
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
SEHGAL LAKSHMAN R0 citations52
BIOVEC LLC
9 patentsUS7501114B2Mar 10, 2009
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC22 citations92
US7481998B2Jan 27, 2009
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC14 citations92
US7179459B2Feb 20, 2007
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC21 citations92
US7687058B2Mar 30, 2010
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC7 citations73
US7670597B2Mar 2, 2010
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC7 citations73
US7803365B2Sep 28, 2010
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC4 citations62
US8367056B2Feb 5, 2013
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
BIOVEC LLC0 citations52
US8048410B2Nov 1, 2011
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
BIOVEC LLC0 citations52
US7713522B2May 11, 2010
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
BIOVEC LLC0 citations52
NORTHFIELD LAB
7 patentsUS4826811AMay 2, 1989
Acellular red blood cell substitute
NORTHFIELD LAB151 citations97
US5194590AMar 16, 1993
Acellular red blood cell substitute
NORTHFIELD LAB107 citations96
US5464814ANov 7, 1995
Acellular red blood cell substitute
NORTHFIELD LAB82 citations95
US6552173B2Apr 22, 2003
Acellular red blood cell substitute
NORTHFIELD LAB15 citations91
US6323320B1Nov 27, 2001
Acellular red blood cell substitute
NORTHFIELD LAB15 citations91
US6133425AOct 17, 2000
Acellular red blood cell substitute
NORTHFIELD LAB18 citations91
US6914127B2Jul 5, 2005
Acellular red blood cell substitute
NORTHFIELD LAB9 citations81